HANGHANG
WU
Investigador de proyecto
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (6)
2024
2023
-
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d
Cancers, Vol. 15, Núm. 16
-
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
JHEP Reports, Vol. 5, Núm. 11
2022
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Cell death & disease, Vol. 13, Núm. 2, pp. 143
2021
-
Fibrotic events in the progression of cholestatic liver disease
Cells, Vol. 10, Núm. 5